DigiPall; a Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
DigiPall; a Randomized Controlled Trial of Digital Patient Reported Outcome and Biomarker Monitoring in Palliative Care
David Blum
382 participants
Jun 11, 2025
INTERVENTIONAL
Conditions
Summary
The aim of this study is to test if a system consisting of a wearable device measuring heartbeats and steps, together with daily communication with a chatbot on the smartphone asking the patients about their symptoms and giving tips, can reduce unplanned hospital readmissions and improve well-being in advanced cancer and severely ill patients.
Eligibility
Inclusion Criteria6
- Patients with established diagnosis of a metastatic cancer/severe illness with limited life expectancy receiving palliative care services
- Estimated life expectancy \<24 months (physician's guess)/ \>3 months
- Karnofsky Index ≥ 50% / ECOG≤ 2
- Aged \>18 years
- Owns and uses a smartphone
- Give written informed consent
Exclusion Criteria2
- Patients under curative treatment
- Relevant cognitive impairment
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DigiPall is an intervention combining a sensor-equipped wearable with a chatbot communicating via WhatsApp on the patient's smartphone. Patients will be asked two questions daily for their subjective rating through WhatsApp on their smartphone, worded slightly differently depending on the measured values for steps, heart rate and compliance as well as the patient's answer the day before.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06615349